Cargando…

A profile of brain reserve in adults at genetic risk of Alzheimer's disease

INTRODUCTION: The apolipoprotein E (APOE) ε4 allele is the greatest genetic risk factor for Alzheimer's disease (AD). Our aim was to identify the structural brain measures that mitigate the negative effect of APOE ε4 on cognition, which would have implications for AD diagnosis and treatment tri...

Descripción completa

Detalles Bibliográficos
Autores principales:	Coughlan, Gillian, Zhukovsky, Peter, Voineskos, Aristotle, Grady, Cheryl
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	John Wiley and Sons Inc. 2021
Materias:	Cognitive & Behavioral Assessment
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8190533/ https://www.ncbi.nlm.nih.gov/pubmed/34136636 http://dx.doi.org/10.1002/dad2.12208

Ejemplares similares

Causal association of cognitive reserve on Alzheimer's disease with putative sex difference
por: Wang, Hao, et al.
Publicado: (2021)

Cardiorespiratory fitness mitigates brain atrophy and cognitive decline in adults at risk for Alzheimer's disease
por: Dougherty, Ryan J., et al.
Publicado: (2021)

Further education improves cognitive reserve and triggers improvement in selective cognitive functions in older adults: The Tasmanian Healthy Brain Project
por: Thow, Megan E., et al.
Publicado: (2017)

Selective familiarity deficits in otherwise cognitively intact aging individuals with genetic risk for Alzheimer's disease
por: Schoemaker, Dorothee, et al.
Publicado: (2015)

Markers of early changes in cognition across cohorts of adults with Down syndrome at risk of Alzheimer's disease
por: Aschenbrenner, Andrew J., et al.
Publicado: (2021)

Cardiorespiratory fitness and cognition in persons at risk for Alzheimer's disease
por: Vesperman, Clayton J., et al.
Publicado: (2022)

Long‐term trajectories and current BMI are associated with poorer cognitive functioning in middle‐aged adults at high Alzheimer's disease risk
por: West, Rebecca K., et al.
Publicado: (2021)

A quadratic function of activation in individuals at risk of Alzheimer's disease
por: Corriveau‐Lecavalier, Nick, et al.
Publicado: (2021)

Apraxia profiles—A single cognitive marker to discriminate all variants of frontotemporal lobar degeneration and Alzheimer's disease
por: Johnen, Andreas, et al.
Publicado: (2018)

Semantic loss marks early Alzheimer's disease‐related neurodegeneration in older adults without dementia
por: Vonk, Jet M. J., et al.
Publicado: (2020)

Quantification of cognitive impairment to characterize heterogeneity of patients at risk of developing Alzheimer's disease dementia
por: Giraldo, Diana L., et al.
Publicado: (2021)

Relationships between big‐five personality factors and Alzheimer's disease pathology in autosomal dominant Alzheimer's disease
por: Aschenbrenner, Andrew J., et al.
Publicado: (2020)

Predicting conversion to dementia in a memory clinic: A standard clinical approach compared with an empirically defined clustering method (latent profile analysis) for mild cognitive impairment subtyping
por: McGuinness, Bernadette, et al.
Publicado: (2015)

Scientific and ethical features of English-language online tests for Alzheimer's disease
por: Robillard, Julie M., et al.
Publicado: (2015)

Sensitivity of composite scores to amyloid burden in preclinical Alzheimer's disease: Introducing the Z-scores of Attention, Verbal fluency, and Episodic memory for Nondemented older adults composite score
por: Lim, Yen Ying, et al.
Publicado: (2015)

Cognitive profiles of patients with mild cognitive impairment due to Alzheimer's versus Parkinson's disease defined using a base rate approach: Implications for neuropsychological assessments
por: Ophey, Anja, et al.
Publicado: (2021)

Can visuospatial measures improve the diagnosis of Alzheimer's disease?
por: Salimi, Shirin, et al.
Publicado: (2017)

Automated text‐level semantic markers of Alzheimer's disease
por: Sanz, Camila, et al.
Publicado: (2022)

Practice effects due to serial cognitive assessment: Implications for preclinical Alzheimer's disease randomized controlled trials
por: Goldberg, Terry E., et al.
Publicado: (2015)

Automatic speech analysis for the assessment of patients with predementia and Alzheimer's disease
por: König, Alexandra, et al.
Publicado: (2015)

Utility of the NIH Toolbox for assessment of prodromal Alzheimer's disease and dementia
por: Hackett, Katherine, et al.
Publicado: (2018)

Analyzing large Alzheimer's disease cognitive datasets: Considerations and challenges
por: Bellio, Maura, et al.
Publicado: (2020)

Odor identification impairment and cholinesterase inhibitor treatment in Alzheimer's disease
por: Motter, Jeffrey N., et al.
Publicado: (2021)

Unsupervised mobile cognitive testing for use in preclinical Alzheimer's disease
por: Papp, Kathryn V., et al.
Publicado: (2021)

Current advances in digital cognitive assessment for preclinical Alzheimer's disease
por: Öhman, Fredrik, et al.
Publicado: (2021)

A cognitive stress test for prodromal Alzheimer's disease: Multiethnic generalizability
por: Curiel Cid, Rosie E., et al.
Publicado: (2019)

Diminished Learning Over Repeated Exposures (LORE) in preclinical Alzheimer's disease
por: Samaroo, Aubryn, et al.
Publicado: (2021)

Prevalent, persistent, and impairing: Longitudinal course and impact of apathy in Alzheimer's disease
por: Grossman, Hillel T., et al.
Publicado: (2022)

Associations between NIH Toolbox Cognition Battery and in vivo brain amyloid and tau pathology in non‐demented older adults
por: Snitz, Beth E., et al.
Publicado: (2020)

The conceptual relevance of assessment measures in patients with mild/mild-moderate Alzheimer's disease
por: Hartry, Ann, et al.
Publicado: (2018)

BHA‐CS: A novel cognitive composite for Alzheimer's disease and related disorders
por: Tsoy, Elena, et al.
Publicado: (2020)

Fractal motor activity regulation and sex differences in preclinical Alzheimer's disease pathology
por: Gao, Lei, et al.
Publicado: (2021)

Sex differences and modifiable dementia risk factors synergistically influence memory over the adult lifespan
por: LaPlume, Annalise A., et al.
Publicado: (2022)

Modeling practice effects in healthy middle-aged participants of the Alzheimer and Families parent cohort
por: Sánchez-Benavides, Gonzalo, et al.
Publicado: (2016)

Time course of neuropsychiatric symptoms and cognitive diagnosis in National Alzheimer's Coordinating Centers volunteers
por: Wise, Elizabeth A., et al.
Publicado: (2019)

Depression screening in cognitively normal older adults: Measurement bias according to subjective memory decline, brain amyloid burden, cognitive function, and sex
por: Thompson, Louisa I., et al.
Publicado: (2020)

Cognitive variability—A marker for incident MCI and AD: An analysis for the Alzheimer's Disease Neuroimaging Initiative
por: Anderson, Eric D., et al.
Publicado: (2016)

δ scores predict mild cognitive impairment and Alzheimer's disease conversions from nondemented states
por: Royall, Donald R., et al.
Publicado: (2017)

Validation of the National Alzheimer's Coordinating Center (NACC) Lewy Body Disease Module neuropsychological tests
por: Rahman‐Filipiak, Annalise, et al.
Publicado: (2022)

Subtle cognitive impairment as a marker of Alzheimer's pathologies and clinical progression in cognitively normal individuals
por: Shen, Xue‐Ning, et al.
Publicado: (2021)

Cannot write session to /tmp/vufind_sessions/sess_igkmdrg193e4k9r8mvihte2tuc